Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Novo Nordisk to Acquire Forma Therapeutics and Expand Presence in Sickle Cell Disease and Rare Blood Disorders
Novo Nordisk and Forma Therapeutics, Holdings Inc. (Nasdaq: FMTX) today announced that they have entered […]
RaySearch and Leo Cancer Care Join Forces to Enable Upright Radiotherapy
A key milestone and partnership for the clinical implementation of upright radiotherapy has been announced. […]
Neukio Biotherapeutics Completed Series A-1 Financing, to Accelerate Discovery and Development of Next Generation Cell Therapy Products
Neukio Biotherapeutics, a company committed to developing novel cell therapy products, announces it has closed $50 […]
Novartis Appoints Fiona Marshall, Ph.D., President of the Novartis Institutes for BioMedical Research as Jay Bradner, M.d., Steps Down From the Executive Committee of Novartis
Novartis today announced that James (Jay) E. Bradner, M.D., will step down from the Executive […]
Avails Medical Awarded Additional $1.7m in CARB-x Funding for the Development of Its Rapid Antibiotic Susceptibility Testing Device to Identify the Most Effective Antibiotic Therapy
Avails Medical, a pioneer in rapid, automated, and fully electrical antibiotic susceptibility testing (eAST™) announced […]
Zimmer Biomet and Surgical Planning Associates Announce Exclusive Multi-Year Co-Marketing Agreement for HipInsight™ Mixed Reality System for Total Hip Replacement
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced […]
Element Biosciences Welcomes Former ThermoFisher Executive Shelly Peariso to their Growing Commercial Team
Element Biosciences, Inc.— developer of the AVITI™ System, a new and disruptive DNA sequencing platform — […]
Insightec Announces Financing up to $200 Million to Fund Continued Growth
Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care, today […]
Ensysce Biosciences and Quotient Sciences Announce a Partnership on the Development and Clinical Testing of Ensysce's PF614-MPAR, a Novel Opioid Designed to Prevent Abuse and Overdose
Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC) (OTC PINK: ENSCW), a clinical-stage biotech company […]
Spatial Biology CRO Flagship Biosciences Acquires Pharma Services Business from Interpace Biosciences
Flagship Biosciences, Inc., a leader in spatial biology and biomarker analytics services, announced the acquisition […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more